Literature DB >> 15070069

Glucose-stimulated acrolein production from unsaturated fatty acids.

R Medina-Navarro1, G Duran-Reyes, M Diaz-Flores, J J Hicks, J Kumate.   

Abstract

Glucose auto-oxidation may be a significant source of reactive oxygen species (ROS), and also be important in the lipid peroxidation process, accompanied by the release of toxic reactive products. We wanted to demonstrate that acrolein can be formed directly and actively from free fatty acids in a hyperglycemic environment. A suspension of linoleic and arachidonic acids (2.5 mM) was exposed to different glucose concentrations (5, 10 and 15 mmol/L) in vitro. The samples were extracted with organic solvents, partitioned, followed at 255-267 nm, and analysed using capillary electrophoresis and mass spectroscopy. The total release of aldehydes significantly (P < 0.01) increased from 1.0 to 5.1, 8.3 and 13.1 micromol/L after 6 hours of incubation, proportional to glucose concentrations. It was possible to verify a correlate hydroperoxide formation as well. Among the lipid peroxidation products, acrolein (5% of total) and its condensing product, 4-hydroxy-hexenal, were identified. From the results presented here, it was possible to demonstrate the production of acrolein, probably as a fatty acid product, due to free radicals generated from the glucose auto-oxidation process. The results led us to propose that acrolein, which is one of the most toxic aldehydes, is produced during hyperglycemic states, and may lead to tissue injury, as one of the initial problems to be linked to high levels of glucose in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070069     DOI: 10.1191/0960327104ht416oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  8 in total

1.  Human breath gas analysis in the screening of gestational diabetes mellitus.

Authors:  Susanne Halbritter; Mattia Fedrigo; Vera Höllriegl; Wilfried Szymczak; Joerg M Maier; Anette-Gabriele Ziegler; Michael Hummel
Journal:  Diabetes Technol Ther       Date:  2012-07-09       Impact factor: 6.118

2.  Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism.

Authors:  S O Awe; A S O Adeagbo; S E D'Souza; A Bhatnagar; D J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2006-08-26       Impact factor: 4.219

3.  Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus?

Authors:  G Bjelakovic; S Beninati; B Bjelakovic; D Sokolovic; T Jevtovic; I Stojanovic; S Rossi; C Tabolacci; G Kocić; D Pavlovic; Lj Saranac; S Zivic
Journal:  Mol Cell Biochem       Date:  2010-04-20       Impact factor: 3.396

4.  Acrolein generation stimulates hypercontraction in isolated human blood vessels.

Authors:  D J Conklin; A Bhatnagar; H R Cowley; G H Johnson; R J Wiechmann; L M Sayre; M B Trent; P J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2006-09-29       Impact factor: 4.219

5.  A possible role of acrolein in diabetic retinopathy: involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia.

Authors:  Jeffery Grigsby; Brandi Betts; Eileen Vidro-Kotchan; Richard Culbert; Andrew Tsin
Journal:  Curr Eye Res       Date:  2012-08-20       Impact factor: 2.424

6.  Acrolein metabolites, diabetes and insulin resistance.

Authors:  Aliya G Feroe; Roberta Attanasio; Franco Scinicariello
Journal:  Environ Res       Date:  2016-03-15       Impact factor: 6.498

7.  Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage.

Authors:  Rafael Medina-Navarro; Renato Nieto-Aguilar; Cleto Alvares-Aguilar
Journal:  Lipids Health Dis       Date:  2011-11-07       Impact factor: 3.876

8.  Diet induces hepatocyte protection in fatty liver disease via modulation of PTEN signaling.

Authors:  Yuka Ikeda; Mutsumi Murakami; Yukie Nakagawa; Ai Tsuji; Yasuko Kitagishi; Satoru Matsuda
Journal:  Biomed Rep       Date:  2020-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.